Phio Pharmaceuticals Corp.
NASDAQPhio Pharmaceuticals has seen a dramatic shift in its lending market over the past two weeks. Cost to borrow has collapsed from a peak near 223% in early April to 40.7% as of May 11 — a 67% weekly drop. Short interest has also fallen sharply, down 23.9% in a week to 3.28% of free float. The story here is the speed of the reversal. For most of…
PHIO short interest falls 23.9% over one week to 3.28% of float, while cost to borrow plummets 66.8% to 40.66%.
Snapshot as of 26 Jun 2026
Phio Pharmaceuticals has seen a dramatic shift in its lending market over the past two weeks. Cost to borrow has collapsed from a peak near 223% in early April to 40.7% as of May 11 — a 67% weekly drop. Short interest…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for PHIO — free to start on ORTEX.
Sign up for free →Open PHIO on ORTEXPulses are triggered by ORTEX's live data feeds. The full signal history, thresholds, and alerts are on ORTEX.
Live PHIO data →